Biotech Stock Roundup: Amgen’s Enbrel Patent Win, AMRN’s Setback & More Yahoo Finance
It was a busy week for the biotech sector after the second-quarter earnings with collaborations and pipeline updates taking center stage. While Amgen AMGN …
Biotech Stock Roundup: Amgen’s Enbrel Patent Win, AMRN’s Setback & More Yahoo Finance
It was a busy week for the biotech sector after the second-quarter earnings with collaborations and pipeline updates taking center stage. While Amgen AMGN …